Suppr超能文献

急诊次全肝切除术:对乙酰氨基酚所致急性肝衰竭的新概念:通过辅助原位肝移植进行临时肝支持可实现长期成功。

Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success.

作者信息

Lodge J Peter A, Dasgupta Dowmitra, Prasad K Rajendra, Attia Magdy, Toogood Giles J, Davies Mervyn, Millson Charles, Breslin Niall, Wyatt Judith, Robinson Philip J, Bellamy Mark C, Snook Nicola, Pollard Stephen G

机构信息

HPB and Transplant Unit, St James's University Hospital, Leeds, United Kingdom.

出版信息

Ann Surg. 2008 Feb;247(2):238-49. doi: 10.1097/SLA.0b013e31816401ec.

Abstract

INTRODUCTION

Acetaminophen (paracetamol) overdose (AOD) has recently emerged as the leading cause of acute liver failure (ALF) in the United States, with an incidence approaching that seen in the United Kingdom. We describe a new way to treat AOD ALF patients fulfilling King's College criteria for "super-urgent" liver transplantation.

METHODS

Beginning in June 1998, we have been piloting a clinical program of subtotal hepatectomy and auxiliary orthotopic liver transplantation (ALT) for AOD ALF. Our technique is based on the following principles: (1) subtotal hepatectomy; (2) auxiliary transplantation of a whole liver graft; (3) gradual withdrawal of immunosuppression after recovery. Results were compared with patients who had undergone an orthotopic liver transplantation (OLT) for AOD ALF in the same period. Quality of life comparisons were made using the SF36 questionnaire.

RESULTS

Thirteen patients underwent this procedure between June 1998 and March 2005. Median survival is 68 months (range, 0-102 m). Actual survival data show that 9 of 13 patients are alive (69%) compared with 7 of 13 OLT patients (54%). One ALT patient required a retransplantation with an OLT due to hepatic vein thrombosis, and immunosuppression is therefore maintained. The other 8 surviving ALT patients are off immunosuppression. These 8 ALT patients have normal liver function and have a better quality of life compared with the 7 surviving OLT patients.

CONCLUSION

Our results with this new technique are encouraging: 69% actual survival, no long-term immunosuppression requirement, and improved quality of life in the 62% successful cases.

摘要

引言

对乙酰氨基酚(扑热息痛)过量服用(AOD)最近已成为美国急性肝衰竭(ALF)的主要原因,其发病率接近英国。我们描述了一种治疗符合国王学院“超紧急”肝移植标准的AOD-ALF患者的新方法。

方法

从1998年6月开始,我们一直在试行一项针对AOD-ALF的次全肝切除术和辅助原位肝移植(ALT)的临床方案。我们的技术基于以下原则:(1)次全肝切除术;(2)全肝移植物的辅助移植;(3)恢复后逐渐停用免疫抑制剂。将结果与同期接受原位肝移植(OLT)治疗AOD-ALF的患者进行比较。使用SF36问卷进行生活质量比较。

结果

1998年6月至2005年3月期间,13例患者接受了该手术。中位生存期为68个月(范围0 - 102个月)。实际生存数据显示,13例ALT患者中有9例存活(69%),而13例OLT患者中有7例存活(54%)。1例ALT患者因肝静脉血栓形成需要进行OLT再次移植,因此维持免疫抑制。其他8例存活的ALT患者已停用免疫抑制剂。与7例存活的OLT患者相比,这8例ALT患者肝功能正常,生活质量更好。

结论

我们这项新技术的结果令人鼓舞:实际生存率为69%,无需长期免疫抑制,62%的成功病例生活质量得到改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验